Zhang L, Miller R G, Zhang J
Department of Cellular and Molecular Pathology, Toronto Hospital Research Institute, University of Toronto, Canada.
J Exp Med. 1996 May 1;183(5):2065-73. doi: 10.1084/jem.183.5.2065.
Clonal deletion via activation-induced apoptosis (AIA) of antigen-specific T cells (ASTC) plays a very important role in the induction of peripheral tolerance. However, none of the studies performed so far has shown a complete deletion of ASTC, a small population always persisting in the periphery. The mechanism by which this small population of ASTC escapes AIA has not been determined. Since the existence of these ASTC may influence the outcome of autoimmune diseases and long-term graft survival, we have characterized the properties of these residual ASTC in vivo with the objective of determining mechanisms that may contribute to their persistence. It was found that the resistance of the residual ASTC to AIA is not due to lack of activation or Fas/Fas-L expression. Compared to those susceptible to AIA, the residual ASTC express a high level of Th2-type cytokines that may help them to escape from AIA. Furthermore, they are able to suppress proliferation of other ASTC, suggesting they may, in fact, prolong tolerance in vivo.
通过抗原特异性T细胞(ASTC)的激活诱导凋亡(AIA)进行的克隆清除在外周耐受的诱导中起着非常重要的作用。然而,迄今为止进行的研究均未显示ASTC完全清除,总有一小部分细胞在外周持续存在。这一小部分ASTC逃避AIA的机制尚未确定。由于这些ASTC的存在可能影响自身免疫性疾病的结局和长期移植物存活,我们已在体内对这些残留ASTC的特性进行了表征,目的是确定可能导致其持续存在的机制。结果发现,残留ASTC对AIA的抗性并非由于缺乏激活或Fas/Fas-L表达。与易受AIA影响的细胞相比,残留ASTC表达高水平的Th2型细胞因子,这可能有助于它们逃避AIA。此外,它们能够抑制其他ASTC的增殖,表明它们实际上可能会延长体内的耐受性。